Human Tetanus Immune Globulin (TIG) is a sterile solution of gamma globulin containing protective antibodies against the toxin produced by Clostridium tetani. As a critical component of emergency trauma management, wholesale TIG supplies are essential for hospitals, military medical units, and national stockpiles. Unlike equine-derived antitoxins, human TIG offers significantly lower risks of hypersensitivity reactions, making it the "Gold Standard" for passive immunization.
Jiangxi Serum Pharma Industries Co., Ltd. leverages a decade of pharmaceutical expertise to supply high-purity TIG that meets stringent BP, USP, and EP standards. Our role as a primary exporter from China bridges the gap between sophisticated biological manufacturing and global clinical needs.
The global market for Human TIG is currently experiencing a CAGR of 5.4%. Demand is driven by rising trauma incidences in developing nations and the phasing out of older equine-based serums. China has emerged as a key manufacturing hub, utilizing advanced Cohn fractionation processes to ensure high yield and safety.
TIG production is dependent on human plasma collection from hyper-immunized donors. This creates a supply ceiling, making wholesale procurement and long-term supply agreements critical for national health security. We ensure supply chain resilience through diversified sourcing and cold-chain logistics optimization.
Stringent WHO guidelines on viral inactivation (S/D method and Nanofiltration) have raised the entry barrier for manufacturers. Our products strictly adhere to these safety protocols, ensuring zero transmission risk for blood-borne pathogens.
The industry is moving toward "Synthetic TIG." While plasma-derived products remain the standard, R&D into recombinant human monoclonal antibodies (mAbs) for tetanus toxin neutralization is accelerating. This promises a future free from donor dependency.
To overcome cold-chain challenges in remote areas, there is an increasing trend toward lyophilized (freeze-dried) TIG. This stable form allows for easier storage and transport at higher temperatures without losing potency.
Innovation in pre-filled syringes (PFS) and auto-injectors is making TIG more accessible for frontline military and disaster relief scenarios where immediate administration is vital.
Our TIG manufacturing follows a rigorous technological pathway to ensure maximum efficacy and safety:
This roadmap ensures that every 250 IU or 500 IU vial delivered to our clients contains the precise concentration of IgG required for immediate toxin neutralization.
In high-traffic urban hospitals, TIG is administered to patients with "tetanus-prone" wounds (deep punctures, soil contamination) who have an uncertain vaccination history.
In regions where maternal vaccination is low, TIG is a lifesaving intervention to prevent Neonatal Tetanus, often distributed through NGOs and UN healthcare programs.
For combat units, TIG is a standard component of medical kits to manage shrapnel wounds and blast injuries where immediate surgical debridement might be delayed.
Jiangxi Serum Pharma provides more than just products; we provide comprehensive biological solutions:
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Currently, we have already cooperated with our partners on the customization of Pre-Mix, Co-Crystallization and Bio-Fermentation products service. Our nutritional ingredients cover several categories as plant extracts, plant oils & proteins, probiotics and other specialties.
TAT is derived from equine (horse) serum and has a higher risk of allergic reactions and serum sickness. TIG is derived from human plasma, has a longer half-life (approx. 25 days vs 2 days), and is much safer for the patient.
Human TIG must be stored and transported under refrigerated conditions (2°C to 8°C). It should never be frozen, and exposure to light should be minimized.
The standard adult dose for prophylaxis is 250 IU administered by deep intramuscular injection. If the wound is severely contaminated or more than 24 hours old, the dose may be increased to 500 IU.
Yes. This is known as active-passive immunization. However, they must be administered at different injection sites using different syringes to prevent the TIG from neutralizing the vaccine.
